Adolescents Seeking COVID Vaccination (Teen COVID Vax)
NCT05537103 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 454
Last updated 2025-01-10
Summary
Background:
Information is limited on the experience of children aged 15 to 17 who have or have not been vaccinated against COVID-19. Research has assessed attitudes toward COVID-19 vaccination among adults and parents of teenagers. Few surveys have explored attitudes among teens themselves.
Objective:
This anonymous cross-sectional survey of a national sample US teens to find out about their experiences and attitudes on getting vaccinated for COVID-19. This study will be conducted in collaboration with a national firm (Qualtrics) responsible for the recruitment and data collection.
Eligibility:
People aged 15 to 17 years. Participants will come from urban, suburban, and rural areas in the United States. Factors such as race and gender will match US averages.
Participants will only include subjects recruited by Qualtrics from their national panel of available respondents, who have agreed to be contacted by Qualtrics with opportunities to participate in surveys.
Design:
Participants will be contacted by email. The email will include a link to the survey. The emails will be sent only to people who agreed to be contacted about taking surveys.
Participants will complete the survey online. It should take only 10 minutes.
Questions will include the following:
Have participants been vaccinated against COVID-19? Are they in the process of getting vaccinated?
Do they want to be vaccinated?
Have they had trouble getting vaccinated? If so, what kind of barriers did they face?
What reasons have they considered for and against getting vaccinated?
What have their personal experiences been with COVID-19?
What is their primary source of information about COVID-19?
Other questions will ask about:
Household size.
Employment of people in the household.
How many people in the house have been vaccinated.
The primary language spoken at home.
The natural history survey will be anonymous. Participants will not be asked to give their names....
Conditions
- Ease Of Access To Covid Vaccine
Sponsors & Collaborators
-
National Institutes of Health Clinical Center (CC)
lead NIH
Principal Investigators
-
Holly A Taylor, Ph.D. · National Institutes of Health Clinical Center (CC)
Eligibility
- Min Age
- 15 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-09-26
- Primary Completion
- 2023-04-24
- Completion
- 2023-07-12
Countries
- United States
Study Locations
More Related Trials
-
Effectiveness of the Q-HPV Vaccine 9-years Post Vaccination Among HIV Positive Adolescents
NCT05435209 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness and B-memory Cell Response to QHPV Vaccine 9-years Post-vaccination Among HIV-infected Boys and Girls
NCT04920526 ·Status: UNKNOWN
-
Developing a Self-persuasion Intervention Promoting Adolescent HPV Vaccination
NCT02537756 ·Status: COMPLETED ·Phase: NA
-
Developing a Self-persuasion Intervention Promoting Adolescent HPV Vaccination: Feasibility Trial
NCT02535845 ·Status: TERMINATED ·Phase: NA
-
Efficacy, Immunogenicity, and Safety of TURKOVAC Vaccine Versus the CoronaVac Vaccine Against COVID-19 in Healthy Adolescent
NCT05230940 ·Status: COMPLETED ·Phase: PHASE2
-
The STOP-HPV Trial 1: Communication Intervention
NCT03599557 ·Status: COMPLETED ·Phase: NA
-
Text and Talk: A Multi-level Intervention to Increase Provider HPV Vaccine Recommendation Effectiveness
NCT05006833 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Long-Term Follow-up Survey of COVID-19 Vaccine After Vaccination
NCT04941144 ·Status: COMPLETED
-
Prevalence of Genital HPV Infection in Males Following Introduction of Universal Male HPV Vaccination
NCT02003508 ·Status: COMPLETED
-
Integration to Improve Adolescent Health and HPV Vaccination in Laos
NCT06650956 ·Status: RECRUITING ·Phase: NA
-
State Immunization Information Systems to Improve HPV Vaccination Rates
NCT02993965 ·Status: COMPLETED ·Phase: NA
-
Clinical Decision Support Tools to Increase Human Papillomavirus (HPV) Vaccination in Adolescents in Pharmacies
NCT05831540 ·Status: TERMINATED ·Phase: NA
-
Provider Recommendation and HPV Vaccination
NCT05365048 ·Status: RECRUITING ·Phase: NA
-
Safety and Immunogenicity of AdCLD-CoV19-1 OMI as a Booster: A SARS-CoV-2 (COVID-19) Preventive Vaccine
NCT05576623 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Improving HPV Vaccination Rates Among Rural and Native American Adolescents
NCT03801603 ·Status: COMPLETED ·Phase: NA
-
Increasing Optimal Use of HPV Vaccination in Primary Care
NCT04180462 ·Status: COMPLETED ·Phase: NA
-
Educational Intervention to Minimize Disparities in Humanpapillomavirus Vaccination
NCT02145156 ·Status: COMPLETED ·Phase: NA
-
Open-label Safety and Tolerability Study of CoVaccine HT™ in Healthy Volunteers
NCT01015703 ·Status: COMPLETED ·Phase: PHASE1
-
Immunogenicity of HPV Vaccine in Immunosuppressed Children
NCT02263703 ·Status: COMPLETED ·Phase: PHASE3
-
The HPV 9-10 Trial: Early Initiation of HPV Vaccination
NCT04722822 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Impact of a School- and Primary Care-based Multicomponent Intervention on HPV Vaccination Acceptability
NCT04945655 ·Status: COMPLETED ·Phase: NA
-
Patient Decision Aid Tool for HPV Vaccination Among Adults Ages 27-45 Years Old
NCT06435338 ·Status: COMPLETED ·Phase: NA
-
Immunisation for Adolescents Against Serious Communicable Diseases (B Part of it NT)
NCT04398849 ·Status: UNKNOWN
-
PREVENT Pilot HPV - Related Cancers Trial
NCT06738355 ·Status: COMPLETED ·Phase: NA
-
Immunogenicity and Safety of the SpikoGen COVID-19 Vaccine in Children Aged 5 to <12 Years and 12 to <18 Years Compared With Adults Aged 18 to 40 Years
NCT05231590 ·Status: COMPLETED ·Phase: PHASE3